Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
The loss of renal dendritic cells and activation of host adaptive immunity are long-term effects of ischemia/reperfusion injury following syngeneic kidney transplantation.
Ozaki KS, Kimura S, Nalesnik MA, Sico RM, Zhang M, Ueki S, Ross MA, Stolz DB, Murase N.
Kidney Int. 2012 May;81(10):1015-25. doi: 10.1038/ki.2011.458. Epub 2012 Jan 25.
Related citations
High-dose erythropoietin has no effect on short- or long-term graft function following deceased donor kidney transplantation.
Hafer C, Becker T, Kielstein JT, Bahlmann E, Schwarz A, Grinzoff N, Drzymala D, Bonnard I, Richter N, Lehner F, Klempnauer J, Haller H, Traeder J, Fliser D.
Kidney Int. 2012 Feb;81(3):314-20. doi: 10.1038/ki.2011.349. Epub 2011 Oct 19.
Transplant glomerulopathy: it's not always about chronic rejection.
Haas M.
Kidney Int. 2011 Oct;80(8):801-3. doi: 10.1038/ki.2011.192.
Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy.
Baid-Agrawal S, Farris AB 3rd, Pascual M, Mauiyyedi S, Farrell ML, Tolkoff-Rubin N, Collins AB, Frei U, Colvin RB.
Kidney Int. 2011 Oct;80(8):879-85. doi: 10.1038/ki.2011.194. Epub 2011 Jun 22.
RGS4, a GTPase activator, improves renal function in ischemia-reperfusion injury.
Siedlecki AM, Jin X, Thomas W, Hruska KA, Muslin AJ.
Kidney Int. 2011 Aug;80(3):263-71. doi: 10.1038/ki.2011.63. Epub 2011 Mar 16.
Paraprotein 'zippers'.
Bravou V, McLean AG, Loucaidou M, Cairns TD, Cook HT, Roufosse CA.
Kidney Int. 2011 Jul;80(1):126. doi: 10.1038/ki.2011.54. No abstract available.
Higher recipient body mass index is associated with post-transplant delayed kidney graft function.
Molnar MZ, Kovesdy CP, Mucsi I, Bunnapradist S, Streja E, Krishnan M, Kalantar-Zadeh K.
Kidney Int. 2011 Jul;80(2):218-24. doi: 10.1038/ki.2011.114. Epub 2011 Apr 27.
Sirolimus: not so sparing in the Spare-the-Nephron trial.
Shamseddin MK, Gupta A.
Kidney Int. 2011 Jun;79(12):1379; author reply 1379-80. No abstract available.
Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine.
Gronwald W, Klein MS, Zeltner R, Schulze BD, Reinhold SW, Deutschmann M, Immervoll AK, Böger CA, Banas B, Eckardt KU, Oefner PJ.
Kidney Int. 2011 Jun;79(11):1244-53. doi: 10.1038/ki.2011.30. Epub 2011 Mar 9.
Opportunities to deter transplant tourism exist before referral for transplantation and during the workup and management of transplant candidates.
Gill J, Diec O, Landsberg DN, Rose C, Johnston O, Keown PA, Gill JS.
Kidney Int. 2011 May;79(9):1026-31. Epub 2011 Jan 12.
Surveillance of alloantibodies after transplantation identifies the risk of chronic rejection.
Kimball PM, Baker MA, Wagner MB, King A.
Kidney Int. 2011 May;79(10):1131-7. Epub 2011 Jan 26.
Can the nephron be spared?
Flechner SM.
Kidney Int. 2011 Apr;79(8):804-6.
Continuous cognitive improvement 1 year following successful kidney transplant.
Harciarek M, Biedunkiewicz B, Lichodziejewska-Niemierko M, Dębska-Ślizień A, Rutkowski B.
Kidney Int. 2011 Jun;79(12):1353-60. Epub 2011 Mar 9.
Non-HLA antibodies in kidney allograft rejection: convincing concept in need of further evidence.
Regele H.
Kidney Int. 2011 Mar;79(6):583-6.
De novo development of circulating anti-endothelial cell antibodies rather than pre-existing antibodies is associated with post-transplant allograft rejection.
Sun Q, Cheng Z, Cheng D, Chen J, Ji S, Wen J, Zheng C, Liu Z.
Kidney Int. 2011 Mar;79(6):655-62. Epub 2010 Oct 27.
Donor antigen-specific regulatory T-cell function affects outcome in kidney transplant recipients.
Tsaur I, Gasser M, Aviles B, Lutz J, Lutz L, Grimm M, Lange V, Lopau K, Heemann U, Germer CT, Chandraker A, Waaga-Gasser AM.
Kidney Int. 2011 May;79(9):1005-12. Epub 2011 Jan 26.
De novo malignancy is associated with renal transplant tourism.
Tsai MK, Yang CY, Lee CY, Yeh CC, Hu RH, Lee PH.
Kidney Int. 2011 Apr;79(8):908-13. Epub 2011 Jan 26.
Carbon monoxide-releasing molecules protect against ischemia-reperfusion injury during kidney transplantation.
Caumartin Y, Stephen J, Deng JP, Lian D, Lan Z, Liu W, Garcia B, Jevnikar AM, Wang H, Cepinskas G, Luke PP.
Kidney Int. 2011 May;79(10):1080-9. Epub 2011 Jan 26.
Renal transplantation in HIV-infected patients: 2010 update.
Trullas JC, Cofan F, Tuset M, Ricart MJ, Brunet M, Cervera C, Manzardo C, López-Dieguez M, Oppenheimer F, Moreno A, Campistol JM, Miro JM.
Kidney Int. 2011 Apr;79(8):825-42. Epub 2011 Jan 19. Review.
Direct targeting of fibroblast growth factor-inducible 14 protein protects against renal ischemia reperfusion injury.
Hotta K, Sho M, Yamato I, Shimada K, Harada H, Akahori T, Nakamura S, Konishi N, Yagita H, Nonomura K, Nakajima Y.
Kidney Int. 2011 Jan;79(2):179-88. Epub 2010 Oct 6.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on